Latest News and Press Releases

PHILADELPHIA, July 15, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company") announced that it was publicizing the full technical (unedited) report in Japanese, prepared...

PHILADELPHIA, July 12, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company"), announced that it has received a report, prepared by Hideki Hasegawa, M.D. Ph.D., Director,...

PHILADELPHIA, June 15, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx"), announced that the Company executed an exclusive revenue sharing Sales,...

PHILADELPHIA, May 17, 2010 (GLOBE NEWSWIRE) -- As part of its expanding international program Hemispherx Biopharma, Inc. (NYSE Amex:HEB), (the "Company"), announced an agreement with Fountain Medical...

PHILADELPHIA, May 13, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company"), today announced that the Company will participate in the Rodman & Renshaw 6th Annual...

PHILADELPHIA, May 7, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) announced its financial results for the three months ended March 31, 2010. The net loss (including non-cash...

PHILADELPHIA, May 3, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE AMEX:HEB) (the "Company") announced today the formation of an Independent Data Monitoring Committee (DMC) which will...

PHILADELPHIA, April 1, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) is an advanced specialty pharmaceutical company engaged in the clinical development of new drug entities for...

PHILADELPHIA, March 23, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company"), announced today the publication of an editorial entitled "TLR3 agonists as...

PHILADELPHIA, March 15, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company"), announced its financial results for the fiscal year ended December 31, 2009. The net loss...